Performance of the tuberculin skin test and interferon-γ release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Kim, Eun Y ^a   Lim, Ju E ^a   Jung, Ji Y ^a   Son, Ji Y ^a   Lee, Kyung J ^a   Yoon, Yoe W ^a   Park, Byung H ^a   Moon, Jin W ^a   Park, Moo S ^a   Kim, Young S ^a   Kim, Se K ^a   Chang, Joon ^a   Kang, Young A ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BCG VACCINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GAMMA INTERFERON; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TUBERCULIN;

ADULT; AGED; ANEMIA; ARTICLE; CIGARETTE SMOKING; CONTACT EXAMINATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOALBUMINEMIA; HYPOPROTEINEMIA; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; KIDNEY FAILURE; LABORATORY TEST; LIVER CIRRHOSIS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OBSERVATIONAL STUDY; ORGAN TRANSPLANTATION; RENAL REPLACEMENT THERAPY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SKIN TEST; SOUTH KOREA; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; BLOOD; COMPARATIVE STUDY; IMMUNOCOMPROMISED PATIENT; LATENT TUBERCULOSIS; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; YOUNG ADULT;

EID: 73449118239     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-207     Document Type: Article

References (30)

1. WHO report 2009: global tuberculosis control epidemiology, strategy, financing. 2009,
2. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994, 72:213-220. 2486541, 8205640.
3. Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002, 347:1860-1866. 10.1056/NEJMcp021045, 12466511.
4. Sepulveda RL, Ferrer X, Latrach C, Sorensen RU. The influence of Calmette-Guerin bacillus immunization on the booster effect of tuberculin testing in healthy young adults. Am Rev Respir Dis 1990, 142:24-28.
5. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis 1993, 17:968-975.
6. Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention. MMWR Recomm Rep 1997, 46:1-10.
7. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 2002, 57:804-809. 10.1136/thorax.57.9.804, 1746436, 12200526.
8. Mazurek GH, Villarino ME. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003, 52:15-18.
9. Ledingham J, Wilkinson C, Deighton C. British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-{alpha} treatments. Rheumatology (Oxford) 2005, 44:1205-1206. 10.1093/rheumatology/kei103, 16172152.
10. Hoffmann H, Loytved G, Bodmer T. [Interferon-gamma release assays in tuberculosis diagnostics]. Internist (Berl) 2007, 48:497-498. 500-496, 10.1007/s00108-007-1827-8, 17393132.
11. Soborg B, Ruhwald M, Hetland ML, Jacobsen S, Andersen AB, Milman N, Thomsen VO, Jensen DV, Koch A, Wohlfahrt J, Ravn P. Comparison of Screening Procedures for Mycobacterium tuberculosis Infection Among Patients with Inflammatory Diseases. J Rheumatol 2009, 36:1876-1884. 10.3899/jrheum.081292, 19648300.
12. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356:1099-1104. 10.1016/S0140-6736(00)02742-2, 11009160.
13. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170:59-64. 10.1164/rccm.200402-179OC, 15059788.
14. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293:2756-2761. 10.1001/jama.293.22.2756, 15941805.
15. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006, 28:24-30. 10.1183/09031936.06.00016906, 16611658.
16. Kim SH, Song KH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009, 122:189-195. 10.1016/j.amjmed.2008.07.028, 19185094.
17. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006, 174:736-742. 10.1164/rccm.200509-1516PP, 16799073.
18. Kobashi Y, Mouri K, Obase Y, Fukuda M, Miyashita N, Oka M. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. Eur Respir J 2007, 30:945-950. 10.1183/09031936.00040007, 17652312.
19. Greenberg JD, Reddy SM, Schloss SG, Kurucz OS, Bartlett SJ, Abramson SB, Bingham CO. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis. J Rheumatol 2008, 35:770-775.
20. Richeldi L, Losi M, D'Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V, Meacci M, Meccugni B, Rumpianesi F, Roversi P, Cerri S, Luppi F, Ferrara G, Latorre I, Gerunda GE, Torelli G, Esposito R, Fabbri LM. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009, 136:198-204. 10.1378/chest.08-2575, 19318676.
21. Shim TS, Koh WJ, Yim JJ, Lew WJ. Treatment of latent tuberculosis infection in Korea. Tuberc Respir Dis 2008, 65:79-90.
22. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September and the sections of this statement. Am J Respir Crit Care Med 1999, 161:S221-247.
23. Cyr L, Francis K. Measures of clinical agreement for nominal and categorical data: the kappa coefficient. Comput Biol Med 1992, 22:239-246. 10.1016/0010-4825(92)90063-S, 1643847.
24. Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 2008, 35:776-781.
25. Hong YP, Kim SJ, Lew WJ, Lee EK, Han YC. The seventh nationwide tuberculosis prevalence survey in Korea, 1995. Int J Tuberc Lung Dis 1998, 2:27-36.
26. Lew WJ, Jung YJ, Song JW, Jang YM, Kim HJ, Oh YM, Lee SD, Kim WS, Kim DS, Kim WD, Shim TS. Combined use of QuantiFERON-TB Gold assay and chest computed tomography in a tuberculosis outbreak. Int J Tuberc Lung Dis 2009, 13:633-639.
27. Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D'Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005, 172:631-635. 10.1164/rccm.200502-196OC, 15961696.
28. Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 2009, 33:586-593. 10.1183/09031936.00107608, 19047313.
29. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009, 33:812-815. 10.1183/09031936.00075008, 19129287.
30. NICE Tuberculosis, Clinical diagnosis and management of tuberculosis and measures for its prevention and control. 2006, , http://guidance.nice.org.uk/CG33/Guidance/pdf/English